4.8 Article

Association between SII and hepatic steatosis and liver fibrosis: A population-based study

Related references

Note: Only part of the references are listed.
Article Oncology

Systemic inflammation with sarcopenia predicts survival in patients with gastric cancer

Yu-Ying Liu et al.

Summary: This study evaluated the prognostic influence of platelet count, platelet lymphocyte ratio, and systemic immune inflammation index on the survival of patients with gastric cancer. A prognostic SS score was established and found to be a reliable predictor of overall survival in gastric cancer patients.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2023)

Article Gastroenterology & Hepatology

Vibration-controlled Transient Elastography for Assessment of Liver Fibrosis at a USA Academic Medical Center

Max Shen et al.

Summary: This study investigated the use of vibration-controlled transient elastography (VCTE) for assessing liver fibrosis in a clinical setting, finding that VCTE is reliable for ruling out cirrhosis but caution is needed when diagnosing cirrhosis due to its low positive predictive value. In some cases, the fibrosis stage determined by VCTE differed significantly from that determined by liver biopsy.

JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY (2022)

Article Medical Laboratory Technology

The association between non-alcoholic fatty liver disease and serum ferritin levels in American adults

Naibin Yang et al.

Summary: This study found that US adults with NAFLD had significantly higher SFLs compared to those without NAFLD. Additionally, the associations between NAFLD and SFLs varied by age and gender.

JOURNAL OF CLINICAL LABORATORY ANALYSIS (2022)

Article Multidisciplinary Sciences

Formyl peptide receptor 2 determines sex-specific differences in the progression of nonalcoholic fatty liver disease and steatohepatitis

Chanbin Lee et al.

Summary: The prevalence of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) is higher in men than premenopausal women. This study demonstrates that formyl peptide receptor 2 (FPR2) levels are regulated by estrogen, and that FPR2 contributes to NAFLD resistance in female mice.

NATURE COMMUNICATIONS (2022)

Article Cardiac & Cardiovascular Systems

Value of the Systemic Immune-Inflammatory Index (SII) in Predicting the Prognosis of Patients With Peripartum Cardiomyopathy

Yuan Zhang et al.

Summary: This study evaluated the prognostic value of the systemic immune-inflammation index (SII) in patients with peripartum cardiomyopathy (PPCM). The results showed that SII and left ventricular end-diastolic dimension (LVEDD) were independent predictors of persistent LV systolic dysfunction in patients with PPCM.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)

Article Peripheral Vascular Disease

Systemic Immune-Inflammation Index as a Predictor of Microvascular Dysfunction in Patients With Cardiac Syndrome X

Erdogan Yasar et al.

Summary: The systemic immune inflammation index (SII) is a new marker that predicts microvascular dysfunction in patients with Cardiac Syndrome X (CSX).

ANGIOLOGY (2022)

Letter Cardiac & Cardiovascular Systems

Atherosclerotic burden and systemic immune inflammation index

Senol Yavuz et al.

ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES (2022)

Article Multidisciplinary Sciences

Prognostic significance of platelet-to-albumin ratio in patients with esophageal squamous cell carcinoma receiving definitive radiotherapy

Zhiyu Huang et al.

Summary: This study found that the platelet to albumin ratio (PAR) before definitive radiotherapy is associated with the prognosis of patients with esophageal squamous cell carcinoma (ESCC). Patients with high PAR had poorer overall survival and progression-free survival. PAR can be a novel, convenient, and inexpensive prognostic indicator for patients with ESCC undergoing definitive radiotherapy.

SCIENTIFIC REPORTS (2022)

Article Geriatrics & Gerontology

Systemic-Immune-Inflammation Index as a Promising Biomarker for Predicting Perioperative Ischemic Stroke in Older Patients Who Underwent Non-cardiac Surgery

Faqiang Zhang et al.

Summary: The study investigated the clinical prognostic values of the preoperative systemic-immune-inflammation index (SII) in older patients undergoing non-cardiac surgery. The results indicated that an elevated SII, based on an optimal cut-off value of 583, was an independent risk factor for perioperative ischemic stroke within 30 days after surgery. This suggests that preoperative SII may serve as a potential prognostic biomarker in predicting ischemic stroke after non-cardiac surgery in elderly patients.

FRONTIERS IN AGING NEUROSCIENCE (2022)

Article Pediatrics

Risk stratification of adolescents for the screening of non-alcoholic fatty liver disease

Gary A. Abrams et al.

Summary: Screening for non-alcoholic fatty liver in adolescents can have a significant impact on reducing the risk of premature mortality in adulthood. Stratifying individuals based on body mass index and metabolic parameters can effectively reduce the number of individuals that need to be screened.

PEDIATRIC OBESITY (2022)

Article Oncology

Associations of systemic inflammation markers with identification of pulmonary nodule and incident lung cancer in Chinese population

Ting Tian et al.

Summary: This study found that the systemic inflammation markers NLR, PLR, and SII were associated with poor lung cancer prognosis. Additionally, high levels of these markers were also found to be associated with an increased risk of positive nodules and lung cancer.

CANCER MEDICINE (2022)

Article Clinical Neurology

Predictive Value of the Systemic Immune Inflammation Index for Adverse Outcomes in Patients With Acute Ischemic Stroke

Yun-Xiang Zhou et al.

Summary: The systemic immune-inflammation index (SII) is associated with short-term adverse outcomes in patients with acute ischemic stroke, and the nomogram can predict the risk of adverse outcomes in these patients.

FRONTIERS IN NEUROLOGY (2022)

Article Endocrinology & Metabolism

Relationship Between Non-Alcoholic Fatty Liver Disease and Degree of Hepatic Steatosis and Bone Mineral Density

Ruijie Xie et al.

Summary: This study found a negative association between non-alcoholic fatty liver disease (NAFLD) and bone mineral density (BMD), and a positive link between advanced fibrosis and cirrhosis with higher BMD.

FRONTIERS IN ENDOCRINOLOGY (2022)

Article Oncology

Preoperative Systemic Immune-Inflammation Index (SII) as a Superior Predictor of Long-Term Survival Outcome in Patients With Stage I-II Gastric Cancer After Radical Surgery

Kang He et al.

Summary: The study demonstrates that SII is a simple yet powerful index with high predictive value for survival outcome in patients with stage I-II GC after radical surgery. Incorporating SII into the conventional model improves the predictive ability for 5-year overall survival.

FRONTIERS IN ONCOLOGY (2022)

Article Oncology

High Systemic Immune Inflammation Index Is Associated With Low Skeletal Muscle Quantity in Resectable Pancreatic Ductal Adenocarcinoma

Mohammad Hosein Aziz et al.

Summary: The study found a strong association between preoperative low skeletal muscle mass quantity and elevated host systemic immune inflammation in patients with resected PDAC. Understanding how systemic inflammation may contribute to changes in body composition or whether reversing these changes may affect the host systemic immune inflammation response could expose new therapeutic possibilities for improving patients' survival outcomes.

FRONTIERS IN ONCOLOGY (2022)

Review Gastroenterology & Hepatology

The establishment of public health policies and the burden of non-alcoholic fatty liver disease in the Americas

Luis Antonio Diaz et al.

Summary: Currently, there is a lack of public health policies targeting NAFLD in the Americas, and there is notable heterogeneity in policies to prevent NAFLD-related conditions. Only a few countries have a registry for NAFLD burden, and efforts to raise awareness are scarce. Urgent implementation of public health policies in the Americas is needed to reduce the burden of NAFLD.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2022)

Article Surgery

Prognostic significance of systemic immune-inflammation index (SII) and platelet-albumin-bilirubin (PALBI) grade in patients with pancreatic cancer undergoing radical surgery

Rongshuang Han et al.

Summary: This study aimed to investigate the prognostic significance of the systemic immune-inflammation index (SII) and platelet-albumin-bilirubin (PALBI) grade in pancreatic cancer patients who underwent radical surgery. The results showed that SII was negatively associated with overall survival and disease-free survival, while PALBI grade was associated with overall survival in patients with pancreatic head cancer. The combination of high SII and high PALBI grade had stronger predictive value for poor prognosis.

GLAND SURGERY (2022)

Article Oncology

Prediction of immune-related adverse events in non-small cell lung cancer patients treated with immune checkpoint inhibitors based on clinical and hematological markers: Real-world evidence

Huiru Xu et al.

Summary: This study aimed to establish a prediction model for immune-related adverse events (irAEs) in patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICIs). The study found that treatment lines, aspartate aminotransferase (AST), lactate dehydrogenase (LDH), absolute lymphocyte count (ALC), and systemic immune inflammation index were independent risk factors for the onset of irAEs. The prediction model showed good efficiency in predicting the risk of irAEs.

EXPERIMENTAL CELL RESEARCH (2022)

Article Oncology

Predictive significance of inflammatory indexes in metastatic nonsmall cell lung cancer patients treated with platinum-doublet chemotherapy

Mesut Yilmaz et al.

Summary: This study aimed to analyze the predictive role of the systemic immune-inflammation index (SII), neutrophil-to-lymphocyte ratio (NLR), and prognostic nutritional index (PNI) in patients with advanced NSCLC treated with first-line platinum-doublet chemotherapy. The results showed that high inflammatory indexes were associated with low chemotherapy response rate.

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2022)

Article Radiology, Nuclear Medicine & Medical Imaging

Comparison of point shear wave elastography and transient elastography in the evaluation of patients with NAFLD

Giulio Argalia et al.

Summary: This study compared the diagnostic accuracy of point shear wave elastography (pSWE) and transient elastography (TE) in evaluating fibrosis stage in non-alcoholic fatty liver disease (NAFLD). The results showed that TE was significantly better than pSWE in diagnosing fibrosis stage >= F2, while there were no significant differences between TE and pSWE in diagnosing fibrosis stage >= F1, >= F3, and F4.

RADIOLOGIA MEDICA (2022)

Article Geriatrics & Gerontology

Evaluating the systemic immune-inflammation index for in-hospital and long-term mortality in elderly non-ST-elevation myocardial infarction patients

Ahmet Lutfullah Orhan et al.

Summary: This study aimed to evaluate the predictive value of SII for in-hospital and long-term mortality in elderly NSTEMI patients. The results showed that SII was independently associated with the risk of in-hospital and long-term mortality, and it could serve as a good predictive indicator.

AGING CLINICAL AND EXPERIMENTAL RESEARCH (2022)

Article Gastroenterology & Hepatology

Prognostic Nutritional Index and Systemic Immune-Inflammation Index Predict the Prognosis of Patients with HCC

Dong Wang et al.

Summary: This study found that PNI and SII could be important prognostic parameters for HCC patients who underwent hepatectomy.

JOURNAL OF GASTROINTESTINAL SURGERY (2021)

Article Endocrinology & Metabolism

High Prevalence of Advanced Liver Fibrosis Assessed by Transient Elastography Among US Adults With Type 2 Diabetes

Stefano Ciardullo et al.

Summary: The prevalence of liver steatosis and fibrosis is high in patients with T2DM from the United States, with obesity being a major risk factor. Screening for these conditions among patients with diabetes is recommended based on the study results.

DIABETES CARE (2021)

Article Geriatrics & Gerontology

Association Between Systemic Immune-Inflammation Index and Diabetic Depression

Jie Wang et al.

Summary: The study investigated the relationship between diabetic depression and SII levels, finding that high SII level is an independent risk factor for diabetic depression. The study also suggests that SII may be an easily accessible and cost-effective strategy for identifying depression in patients with diabetes.

CLINICAL INTERVENTIONS IN AGING (2021)

Article Gastroenterology & Hepatology

Hepatic Fibrosis Associates With Multiple Cardiometabolic Disease Risk Factors: The Framingham Heart Study

Michelle T. Long et al.

Summary: In a community-based cohort, hepatic fibrosis defined by VCTE was associated with multiple cardiovascular risk factors (including obesity, metabolic syndrome, diabetes, hypertension, and high-density lipoprotein cholesterol), even after adjusting for covariates and CAP. Additional longitudinal studies are needed to determine the impact of hepatic fibrosis on incident cardiovascular disease risk factors or events.

HEPATOLOGY (2021)

Article Cell Biology

Systemic Immune-Inflammation Index Is a Prognostic Predictor in Patients with Intrahepatic Cholangiocarcinoma Undergoing Liver Transplantation

Ao Ren et al.

Summary: In patients with intrahepatic cholangiocarcinoma undergoing liver transplantation, a higher systemic immune inflammation index (SII) was associated with poorer prognosis, with SII greater than or equal to 447.48x10^9/L being an independent prognostic factor for overall survival. This suggests that SII can be a useful predictor for survival in these patients.

MEDIATORS OF INFLAMMATION (2021)

Article Endocrinology & Metabolism

Statin use is associated with lower prevalence of advanced liver fibrosis in patients with type 2 diabetes

Stefano Ciardullo et al.

Summary: The study found that the use of statins in patients with type 2 diabetes could reduce the risk of advanced liver fibrosis, with no significant interaction with steatosis. Therefore, specific randomized controlled trials with statins are recommended due to the lack of approved therapies for NAFLD-fibrosis.

METABOLISM-CLINICAL AND EXPERIMENTAL (2021)

Review Medicine, General & Internal

Non-alcoholic fatty liver disease

Elizabeth E. Powell et al.

Summary: Non-alcoholic fatty liver disease (NAFLD) is a common global health issue with significant associations with metabolic syndrome and type 2 diabetes, leading to serious complications like cirrhosis and hepatocellular carcinoma. While cardiovascular disease and extrahepatic malignancy are the main causes of death in NAFLD patients, advanced liver fibrosis is a key prognostic marker for liver-related outcomes and overall mortality.

LANCET (2021)

Review Medicine, General & Internal

Liver cirrhosis

Pere Gines et al.

Summary: Cirrhosis is a widespread disease with various causes, leading to portal hypertension, systemic inflammation, and liver failure. Early diagnosis and management of complications are crucial to prevent progression to decompensated cirrhosis. Liver transplantation may be necessary in severe cases.

LANCET (2021)

Article Immunology

Crosstalk Between Plasma Cytokines, Inflammation, and Liver Damage as a New Strategy to Monitoring NAFLD Progression

Tereza C. M. Fontes-Cal et al.

Summary: Cytokines play a role in the immunopathogenesis of NAFLD, with IL-6 levels higher in NASH patients and associated with lower IL-10/IL-6 ratio. NASH patients are high producers of IL-12 and IL-6, while NAFL patients are not high producers of any evaluated cytokines. Different correlations between cytokines and clinical parameters were observed, with IL-12 and IL-10 negatively correlated in the NAFL group, whereas IL-12 and TNF positively correlated with liver fibrosis parameters in the NASH group.

FRONTIERS IN IMMUNOLOGY (2021)

Article Gastroenterology & Hepatology

Racial and ethnic disparities in non-alcoholic fatty liver disease in the USA

Nicole E Rich et al.

Lancet Gastroenterology & Hepatology (2021)

Review Gastroenterology & Hepatology

Case-finding strategies in non-alcoholic fatty liver disease

Jerome Boursier et al.

Summary: Diagnosing and managing non-alcoholic fatty liver disease (NAFLD) patients remains challenging, highlighting the importance of strengthening non-invasive detection methods for early diagnosis and improved treatment outcomes. The active participation of general practitioners and physicians managing metabolic disorders is crucial in addressing the issue of evaluating a large number of patients.

JHEP REPORTS (2021)

Article Gastroenterology & Hepatology

Nonalcoholic fatty liver disease: modulating gut microbiota to improve severity?

Judith Aron-Wisnewsky et al.

GASTROENTEROLOGY (2020)

Article Gastroenterology & Hepatology

Prevalence and Risk Factors of Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Without Steatohepatitis

Serena Pelusi et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)

Article Gastroenterology & Hepatology

Past, present and future perspectives in nonalcoholic fatty liver disease

Arun J. Sanyal

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)

Review Gastroenterology & Hepatology

Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease

Laurent Castera et al.

GASTROENTEROLOGY (2019)

Review Gastroenterology & Hepatology

Macrophages in obesity and non-alcoholic fatty liver disease: Crosstalk with metabolism

Sander Lefere et al.

JHEP REPORTS (2019)

Editorial Material Oncology

Systemic immune-inflammation index in germ-cell tumours: search for a biological prognostic biomarker

Costantine Albany

BRITISH JOURNAL OF CANCER (2018)

Review Biochemistry & Molecular Biology

Mechanisms of NAFLD development and therapeutic strategies

Scott L. Friedman et al.

NATURE MEDICINE (2018)

Article Multidisciplinary Sciences

Hepatocyte-secreted DPP4 in obesity promotes adipose inflammation and insulin resistance

Devram S. Ghorpade et al.

NATURE (2018)

Article Multidisciplinary Sciences

The gut microbiota in infants of obese mothers increases inflammation and susceptibility to NAFLD

Taylor K. Soderborg et al.

NATURE COMMUNICATIONS (2018)

Article Gastroenterology & Hepatology

Systemic immune-inflammation index for predicting prognosis of colorectal cancer

Jian-Hui Chen et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2017)

Review Gastroenterology & Hepatology

Innate Immunity and Inflammation in NAFLD/NASH

Marco Arrese et al.

DIGESTIVE DISEASES AND SCIENCES (2016)

Article Surgery

Pro- and Anti-inflammatory Cytokines in Steatosis and Steatohepatitis

Fabiola Rabelo et al.

OBESITY SURGERY (2010)

Article Gastroenterology & Hepatology

Liver stiffness values in apparently healthy subjects: Influence of gender and metabolic syndrome

Dorninique Roulot et al.

JOURNAL OF HEPATOLOGY (2008)

Article Gastroenterology & Hepatology

Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2

John Willy Haukeland et al.

JOURNAL OF HEPATOLOGY (2006)

Article Gastroenterology & Hepatology

Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults

SH Park et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2006)

Article Gastroenterology & Hepatology

Chronological development of elevated aminotransferases in a nonalcoholic population

A Suzuki et al.

HEPATOLOGY (2005)